Neupro

Active Ingredient(s): Rotigotine
FDA Approved: * May 9, 2007
Pharm Company: * SCHWARZ
Category: Parkinsons

Rotigotine, sold under the brand name Neupro among others, is a dopamine agonist of the non-ergoline class of medications indicated for the treatment of Parkinson's disease (PD) and restless legs syndrome (RLS).[1][2] It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours.[1] Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Neupro 1 mg/24h Transdermal Patch, Extended Release
NDC: 50474-801
Labeler:
Ucb, Inc.
Neupro 2 mg/24h Transdermal Patch, Extended Release
NDC: 50474-802
Labeler:
Ucb, Inc.
Neupro 3 mg/24h Transdermal Patch, Extended Release
NDC: 50474-803
Labeler:
Ucb, Inc.
Neupro 4 mg/24h Transdermal Patch, Extended Release
NDC: 50474-804
Labeler:
Ucb, Inc.
Neupro 6 mg/24h Transdermal Patch, Extended Release
NDC: 50474-805
Labeler:
Ucb, Inc.
Neupro 8 mg/24h Transdermal Patch, Extended Release
NDC: 50474-806
Labeler:
Ucb, Inc.
Neupro Kit
NDC: 50474-808
Labeler:
Ucb, Inc.